📰 Amgen News
Page 68 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
April 30, 2024
Microsoft Corporation beats earnings expectations. Reported EPS is $2.94, expectations were $2.82.
April 30, 2024
Sandoz resolves patent litigation with Amgen, paving the way for the launch of denosumab biosimilars Jubbonti and Wyost.
April 30, 2024
Steele Capital Management Inc. bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 1,031 shares of the medical research company’s stock, valued at approximately $297,000. A number of other institutional investors have […]
April 30, 2024
LLY earnings call for the period ending March 31, 2024.
April 30, 2024
Auxano Advisors LLC lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 7.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,459 shares of the medical research company’s stock after selling 187 shares during the quarter. Auxano Advisors LLC’s holdings […]
April 30, 2024
Auxano Advisors LLC cut its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 7.1% during the 4th quarter, HoldingsChannel reports. The fund owned 2,459 shares of the medical research company’s stock after selling 187 shares during the quarter. Auxano Advisors LLC’s holdings in Amgen were worth $708,000 at the end of the […]
April 30, 2024
LLY earnings call for the period ending March 31, 2024.
April 30, 2024
Epic Trust Investment Advisors LLC lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,211 shares of the medical research company’s stock after selling 70 shares during the quarter. Epic […]
April 29, 2024
Fiduciary Group LLC lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 7.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 33,381 shares of the medical research company’s stock after selling 2,828 shares during the quarter. Amgen makes […]
April 29, 2024
Adell Harriman & Carpenter Inc. boosted its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,263 shares of the medical research company’s stock after acquiring an additional 170 shares […]